Overview of lethal human coronaviruses
暂无分享,去创建一个
Wei Cheng | Wei Cheng | Toufic El Arnaout | B. Chen | Er-Kang Tian | B. He | Lejin Tian | Ruiying Han | Shuangwen Wang | Qianrong Xiang | Shu Zhang | Bin Chen | Er-Kang Tian | Bin He | Lejin Tian | Ruiying Han | Shuangwen Wang | Qianrong Xiang | Shu Zhang | Toufic El Arnaout | Erkang Tian | Shuangwen Wang | Ruiying Han
[1] Shibo Jiang,et al. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design , 2014, Vaccine.
[2] Lin-Fa Wang,et al. Review of Bats and SARS , 2006, Emerging infectious diseases.
[3] F. Weber,et al. Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist , 2013, Journal of Virology.
[4] Sangdun Choi,et al. Structural insights into the Middle East respiratory syndrome coronavirus 4a protein and its dsRNA binding mechanism , 2017, Scientific Reports.
[5] X. L. Liu,et al. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.
[6] Qiang Zhou,et al. Structure of dimeric full-length human ACE2 in complex with B0AT1 , 2020, bioRxiv.
[7] Rajaa Al-Raddadi,et al. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome , 2017, American journal of respiratory and critical care medicine.
[8] J. Sung,et al. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients , 2004, Clinical Microbiology and Infection.
[9] Tae-Jin Kang,et al. Expression of B subunit of E. coli heat-labile enterotoxin in the progenies of transgenic tobacco bred by crossing nuclear- and chloroplast-transgenic lines. , 2019, Protein expression and purification.
[10] Cheng-wei Lu,et al. 2019-nCoV transmission through the ocular surface must not be ignored , 2020, The Lancet.
[11] Edith Jasny,et al. New Vaccine Technologies to Combat Outbreak Situations , 2018, Front. Immunol..
[12] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[13] Jiahua He,et al. Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 , 2020, Viruses.
[14] K. Holmes,et al. SARS-associated coronavirus. , 2003, The New England journal of medicine.
[15] Qingling Zhang,et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.
[16] F. Lai,et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome , 2005, Kidney International.
[17] R. Favory,et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases , 2014, Journal of Clinical Virology.
[18] J. Peiris,et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.
[19] J. Yu,et al. DNA Vaccine of SARS-Cov S Gene Induces Antibody Response in Mice , 2004, Acta biochimica et biophysica Sinica.
[20] Chuan Qin,et al. Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways , 2015, The Journal of infectious diseases.
[21] P. Marik,et al. A Descriptive Study , 2015 .
[22] N. Houhou-Fidouh,et al. Focus on Middle East respiratory syndrome coronavirus (MERS-CoV) , 2019, Médecine et Maladies Infectieuses.
[23] Shibo Jiang,et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine , 2004, Biochemical and Biophysical Research Communications.
[24] R. Korstanje,et al. The emerging role of ACE2 in physiology and disease† , 2007, The Journal of pathology.
[25] Z. Memish,et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus , 2017, Science Advances.
[26] D. Swerdlow,et al. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.
[27] Yi Xiao,et al. Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV) , 2020, bioRxiv.
[28] B. Fielding,et al. MERS-CoV: Understanding the Latest Human Coronavirus Threat , 2018, Viruses.
[29] P. Jahrling,et al. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus , 2016, Journal of Virology.
[30] C. Hsiao,et al. The SARS coronavirus nucleocapsid protein – Forms and functions , 2014, Antiviral Research.
[31] Xin Li,et al. Global Epidemiology of Bat Coronaviruses , 2019, Viruses.
[32] Bo Zhang,et al. Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.
[33] Shibo Jiang,et al. Prospects for a MERS-CoV spike vaccine , 2018, Expert review of vaccines.
[34] Lanjuan Li,et al. Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins , 2019, Engineering.
[35] G. Ha,et al. Development and Validation of a Rapid Immunochromatographic Assay for Detection of Middle East Respiratory Syndrome Coronavirus Antigen in Dromedary Camels , 2015, Journal of Clinical Microbiology.
[36] Z. Memish,et al. The Middle East Respiratory Syndrome (MERS) , 2019, Infectious Disease Clinics of North America.
[37] Yonghong Xiao,et al. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm , 2020, bioRxiv.
[38] D. Weiner,et al. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial , 2019, The Lancet Infectious Diseases.
[39] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[40] Y. Kitade,et al. Association of host tropism of Middle East syndrome coronavirus with the amino acid structure of host cell receptor dipeptidyl peptidase 4. , 2014, Acta virologica.
[41] G. Gao,et al. MERS-CoV spike protein: Targets for vaccines and therapeutics , 2016, Antiviral Research.
[42] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[43] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[44] L. M. Mansky,et al. A Virus-Binding Hot Spot on Human Angiotensin-Converting Enzyme 2 Is Critical for Binding of Two Different Coronaviruses , 2011, Journal of Virology.
[45] Kunqian Yu,et al. Theoretical Study of the anti-NCP Molecular Mechanism of Traditional Chinese Medicine Lianhua-Qingwen Formula (LQF) , 2020 .
[46] K. Moon,et al. A Case Report of a Middle East Respiratory Syndrome Survivor with Kidney Biopsy Results , 2016, Journal of Korean medical science.
[47] G. Gao,et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses , 2016, Trends in Microbiology.
[48] D. Raoult,et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial , 2020, International Journal of Antimicrobial Agents.
[49] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[50] Ali Al-Hazmi,et al. Challenges presented by MERS corona virus, and SARS corona virus to global health , 2016, Saudi Journal of Biological Sciences.
[51] J. Baillie,et al. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury , 2020, The Lancet.
[52] M. McNutt,et al. Pathogenetic mechanisms of severe acute respiratory syndrome , 2007, Virus Research.
[53] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[54] Alimuddin Zumla,et al. Coronaviruses — drug discovery and therapeutic options , 2016, Nature Reviews Drug Discovery.
[55] Ching-lung Lai,et al. SARS‐associated viral hepatitis caused by a novel coronavirus: Report of three cases , 2004, Hepatology.
[56] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[57] Krishna Shankara Narayanan,et al. The Endonucleolytic RNA Cleavage Function of nsp1 of Middle East Respiratory Syndrome Coronavirus Promotes the Production of Infectious Virus Particles in Specific Human Cell Lines , 2018, Journal of Virology.
[58] Daphne A. Cooper,et al. Ribonuclease L and metal-ion–independent endoribonuclease cleavage sites in host and viral RNAs , 2014, Nucleic acids research.
[59] Yang Yang,et al. The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents. , 2014, Viral immunology.
[60] Wenjun Ma,et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV) , 2020, bioRxiv.
[61] Zhihang Peng,et al. Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China , 2020, bioRxiv.
[62] M. Ulaşlı,et al. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle , 2019, Journal of Virology.
[63] F. Taguchi,et al. Studies of Severe Acute Respiratory Syndrome Coronavirus Pathology in Human Cases and Animal Models , 2010, Veterinary pathology.
[64] Yang Yang,et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists , 2013, Protein & Cell.
[65] Lu Lu,et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor , 2014, Nature Communications.
[66] R. Baric,et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.
[67] Zhaohui Zheng,et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein , 2020, bioRxiv.
[68] Lisa E. Gralinski,et al. Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis , 2017, mSphere.
[69] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[70] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[71] Ping Zhu,et al. Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial , 2020, medRxiv.
[72] C. Althaus,et al. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[73] M. Song,et al. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein , 2020, Virus Research.
[74] J. Dennis,et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. , 2003, JAMA.
[75] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[76] A. Haneya,et al. Impact of Acute Kidney Injury on Outcome in Patients With Severe Acute Respiratory Failure Receiving Extracorporeal Membrane Oxygenation* , 2015, Critical care medicine.
[77] J. Laffey,et al. Cell therapy in acute respiratory distress syndrome. , 2018, Journal of thoracic disease.
[78] D. Dimitrov,et al. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies , 2007, Proceedings of the National Academy of Sciences.
[79] A. Debnath,et al. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors , 2004, The Lancet.
[80] Yue Chen,et al. Evolution and variation of 2019-novel coronavirus , 2020, bioRxiv.
[81] Chuan Qin,et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.
[82] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[83] T. Rice,et al. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension , 2018, European Respiratory Journal.
[84] Susan I Gerber,et al. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. , 2015, The New England journal of medicine.
[85] Christian Drosten,et al. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS , 2013, Antiviral Research.
[86] Zhiwei Chen,et al. Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques , 2015, Mucosal Immunology.
[87] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[88] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[89] E. Koonin,et al. Origins and Evolution of the Global RNA Virome , 2018, mBio.
[90] H. Balkhy,et al. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review , 2017, Journal of Infection and Public Health.
[91] S. Kaufmann,et al. Challenges and responses in human vaccine development. , 2014, Current opinion in immunology.
[92] S. Weiss,et al. Murine Coronavirus Mouse Hepatitis Virus Is Recognized by MDA5 and Induces Type I Interferon in Brain Macrophages/Microglia , 2008, Journal of Virology.
[93] C. Chou,et al. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes , 2017, Antiviral Research.
[94] Gary J. Nabel,et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.
[95] Yinying Lu,et al. Two Things about COVID-19 Might Need Attention , 2020 .
[96] B. Bosch,et al. Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody , 2013, Journal of Virology.
[97] Lu Lu,et al. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein , 2014, Virus Research.
[98] S. Al-Benna. Angiotensin-converting enzyme 2 gene expression in human male urological tissues: implications for pathogenesis and virus transmission pathways , 2021, African Journal of Urology.
[99] K. Yuen,et al. Development of a standard treatment protocol for severe acute respiratory syndrome , 2003, The Lancet.
[100] Z. Memish,et al. MERS-CoV as an emerging respiratory illness: A review of prevention methods , 2019, Travel Medicine and Infectious Disease.
[101] Xiu-Jie Wang,et al. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines , 2020, Journal of Genetics and Genomics.
[102] E. Holmes,et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China , 2020, bioRxiv.
[103] D. Hamer. Faculty Opinions recommendation of Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[104] R. C. Macridis. A review , 1963 .
[105] A. Debnath,et al. Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development , 2013, Journal of Virology.
[106] Z. Hong,et al. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study , 2020, Journal of Infection.
[107] D. Dimitrov,et al. Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies , 2014, Journal of Virology.
[108] K. Yuen,et al. Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein , 2014, Science Translational Medicine.
[109] P. Niu,et al. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein , 2019, Nature Communications.
[110] J. Penninger,et al. Angiotensin-converting enzyme 2 in lung diseases , 2006, Current Opinion in Pharmacology.
[111] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[112] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[113] Shibo Jiang,et al. Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors , 2018, Journal of medicinal chemistry.
[114] D. Falzarano,et al. SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.
[115] C. Lam,et al. Severe acute respiratory syndrome: clinical and laboratory manifestations. , 2004, The Clinical biochemist. Reviews.
[116] Lisa E. Gralinski,et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.
[117] O. Jahn,et al. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.
[118] A. Gambotto,et al. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice , 2014, Vaccine.
[119] C. Broder,et al. Identification of a Broad-Spectrum Antiviral Small Molecule against Severe Acute Respiratory Syndrome Coronavirus and Ebola, Hendra, and Nipah Viruses by Using a Novel High-Throughput Screening Assay , 2014, Journal of Virology.
[120] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[121] J. Mascola,et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial , 2008, Vaccine.
[122] Shibo Jiang,et al. De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery , 2018, Journal of medicinal chemistry.
[123] J. Segalés,et al. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels , 2016, Science.
[124] Krystal L. Matthews,et al. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. , 2014, The Journal of general virology.
[125] Jie Hao,et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.
[126] Wenhui Li,et al. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[127] Xiang Li,et al. On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.
[128] Sek-Man Wong,et al. Yeast expression and characterization of SARS-CoV N protein , 2005, Journal of Virological Methods.
[129] B. Bosch,et al. Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus , 2013, Journal of Virology.
[130] Z. Memish,et al. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[131] S. Meo,et al. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. , 2018, European review for medical and pharmacological sciences.
[132] R. Silverman,et al. Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity , 2014, Molecular Cell.
[133] K. Erles,et al. Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease , 2003, Virology.
[134] Susanna K. P. Lau,et al. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease , 2015, Clinical Microbiology Reviews.
[135] Guangdi Li,et al. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) , 2020, Nature Reviews Drug Discovery.
[136] Su-Jin Park,et al. Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] P. Britton,et al. Activation of the Chicken Type I Interferon Response by Infectious Bronchitis Coronavirus , 2014, Journal of Virology.
[138] Yan Liu,et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.
[139] R. Silverman. Viral Encounters with 2′,5′-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response , 2007, Journal of Virology.
[140] G. Whittaker,et al. Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses , 2020, bioRxiv.
[141] Zhigang Tian,et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus , 2020, bioRxiv.
[142] Caution: The clinical characteristics of COVID-19 patients at admission are changing , 2020, medRxiv.
[143] J. Bogdanowicz,et al. REPORT OF THREE CASES. , 1963, American journal of diseases of children.
[144] Shu-Chun Cheng,et al. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus , 2014, Antiviral Research.
[145] Huji Xu,et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes , 2020, bioRxiv.
[146] Lu Lu,et al. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein , 2020, Cellular & Molecular Immunology.
[147] J. Al-Tawfiq,et al. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) , 2019, Travel Medicine and Infectious Disease.
[148] Yi Shi,et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 , 2013, Nature.
[149] M. V. Van Kerkhove,et al. MERS: Progress on the global response, remaining challenges and the way forward , 2018, Antiviral Research.
[150] Willis J. Tompkins,et al. Report from China , 1984, IEEE Engineering in Medicine and Biology Magazine.
[151] R. Silverman,et al. Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity , 2013, Proceedings of the National Academy of Sciences.
[152] Md. Siddikur Rahman,et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? , 2020, International journal of epidemiology.
[153] E. Koonin,et al. Classify viruses — the gain is worth the pain , 2019, Nature.
[154] Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, Emerging microbes & infections.
[155] Tao Liu,et al. Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China , 2020, medRxiv.
[156] R. Lu,et al. Mutations, Recombination and Insertion in the Evolution of 2019-nCoV , 2020, bioRxiv.
[157] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[158] S. Rajagopalan,et al. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. , 2013, Atherosclerosis.
[159] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[160] Julie Dyall,et al. Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection , 2014, Antimicrobial Agents and Chemotherapy.
[161] L. Qiu,et al. A preliminary study , 2018, Medicine.
[162] Rong Zhao,et al. Crystal structure of Middle East respiratory syndrome coronavirus helicase , 2017, PLoS pathogens.
[163] Shifeng Li,et al. Interaction of N‐acetyl‐seryl‐aspartyl‐lysyl‐proline with the angiotensin‐converting enzyme 2–angiotensin‐(1–7)–Mas axis attenuates pulmonary fibrosis in silicotic rats , 2019, Experimental Physiology.
[164] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[165] D. Hui,et al. Severe acute respiratory syndrome and Toronto , 2003, Journal of epidemiology and community health.
[166] R. Baric,et al. Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus , 2013, Journal of Virology.
[167] Z. Deng,et al. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS‐CoV‐2 and Other Respiratory Viruses , 2020, medRxiv.
[168] A. Hill,et al. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice , 2017, Vaccine.
[169] Ping Chen,et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission , 2020, Science China Life Sciences.
[170] F. Pei,et al. Severe Acute Respiratory Syndrome Associated Coronavirus Is Detected in Intestinal Tissues of Fatal Cases , 2005, The American Journal of Gastroenterology.
[171] Z. Memish,et al. Reducing mortality from 2019-nCoV: host-directed therapies should be an option , 2020, The Lancet.
[172] R. Baric,et al. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation , 2016, mBio.
[173] Xu Liu,et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.